The benefit of vaccination against COVID-19 outweighs the potential risk of myocarditis and pericarditis.

Authors:
Klamer TA; Linschoten M; Asselbergs FW.

Journal:
Neth Heart J

Publication Year: 2022

DOI:
10.1007/s12471-022-01677-9

PMCID:
PMC8906525

PMID:
35266090

View on PubMed View on PMC View Publisher

Journal Information

Full Title: Neth Heart J

Abbreviation: Neth Heart J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Cardiac & Cardiovascular Systems

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal

View All Papers from This Journal

Transparency Score

3/6

50.0% Transparent

Transparency Indicators

Click on green indicators to view evidence text

Core Indicators

Data Sharing

Code Sharing

COI Disclosure

Evidence found in paper:

"Conflict of interest T.A. Klamer, M. Linschoten and F.W. Asselbergs declare that they have no competing interests."

Funding Disclosure

Evidence found in paper:

"Funding CAPACITY-COVID is supported by the Dutch Heart Foundation (Hartstichting) (2020B006 CAPACITY), Netherlands Organisation for Health Research and Development (ZonMw) (DEFENCE 10430102110006), EuroQol Research Foundation, Novartis Global, Sanofi Genzyme Europe, Novo Nordisk Nederland, Servier Nederland and Daiichi Sankyo Nederland. M. Linschoten is supported by the Alexandre Suerman Stipend of the University Medical Centre Utrecht. F.W. Asselbergs is supported by the National Institute of Health Research University College London Hospitals Biomedical Research Centre."

Protocol Registration

Open Access

Paper is freely available to read

Additional Indicators

Replication

Novelty Statement

Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025